Jan18

Bio-Optronics Announces $30 Million Growth Investment from Mainsail Partners

ROCHESTER, NY – Bio-Optronics today announced a $30 million investment from Mainsail Partners, a growth equity firm that invests in fast-growing bootstrapped technology companies. Mainsail will partner with the Chief Executive Officer, Dan Kerpelman, and the existing management team to scale the business rapidly. Bio-Optronics will use the capital and Mainsail’s support to accelerate product […]

Nov13

Bio-Optronics® and Complion Announce Integration to Unify Best-in-Class CTMS and eRegulatory Solutions for Clinical Research Organizations

November 13, 2017 – ROCHESTER, NY – Bio-Optronics, the makers of the market leader Clinical Conductor Clinical Trial Management System (CTMS), and Complion, the powerful eRegulatory and document management platform for sites, have partnered to integrate their best-in-class solutions to deliver an industry-leading solution for research organizations. The companies are building upon their long-standing commitment […]